| - Industry | - Sector | Choong-Hwan Lee CEO | KRX SM Exchange | - ISIN |
| South Korea Country | - Employees | - Last Dividend | - Last Split | - IPO Date |
Samik Pharmaceutical Company Ltd. is a renowned pharmaceutical manufacturer based in South Korea, with a robust specialization in the research, development, and production of both prescription and over-the-counter medications. Established in 1973, the company originally concentrated on natural medicine solutions before transitioning into the production of oral pharmaceuticals, aligning with its expansive growth strategy. The Central Research Institute, founded in 1995, exemplifies Samik’s commitment to innovation across several significant therapeutic areas. These include cardiovascular, endocrine, respiratory, gastrointestinal systems, as well as pediatric health and cold remedies. The company’s development pipeline is rich with promising new drug candidates derived from natural substances, a diverse array of generic medications, and enhanced drug formulations, showcasing its dedication to fulfilling a wide spectrum of health needs. Furthermore, Samik is acknowledged for its ability to optimize drug efficacy and safety through cutting-edge technologies such as drug repositioning and formulation control. By making continual investments in research and development, and by fostering synergies with academic institutions, Samik Pharmaceutical plays a critical role in advancing healthcare solutions in South Korea. The company remains devoted to delivering innovative, safe, and globally compliant pharmaceutical products to cater to a diverse patient population.
Samik Pharmaceutical develops a wide range of prescription medications that cover numerous therapeutic areas. These medications are aimed at effectively treating chronic and acute health conditions, ensuring that patients receive the necessary treatment for their specific ailments.
The company offers an extensive selection of over-the-counter drugs designed for self-care. These medications provide accessible solutions for common ailments such as colds, allergies, and minor pain relief, allowing consumers to manage their health with ease.
Samik is heavily invested in research and development, continuously seeking new drug candidates, especially those derived from natural substances. This focus not only hones in on innovating new treatment options but also improves existing formulations to better meet patient needs.
The company produces a variety of generic medications that provide cost-effective alternatives to brand-name drugs while maintaining high standards of quality and efficacy. These generics contribute to broader access to essential medications for patients and healthcare providers.
Utilizing advanced formulation control techniques, Samik Pharmaceutical ensures the optimization of drug delivery and absorption. This commitment to technology enhances the overall efficacy and safety of their pharmaceutical products, resulting in improved patient outcomes.
Samik actively collaborates with academic partners to foster innovation and research in the pharmaceutical field. These partnerships facilitate knowledge exchange and contribute to the development of advanced therapies for various health challenges.